Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.
Harb N, Romey M, Grass A, von Kügelgen F, Hattesohl A, Schäfer JA, Frey L, Mack E, Rinke A, Brendel C, Gremke N, Gschnell M, Görg M, Faoro C, Riera-Knorrenschild J, Gehring S, Litmeyer AS, Maurer E, Adeberg S, Frickel N, Keber U, Nimsky C, Ruchholtz S, Bartsch DK, Burchert A, Rohde G, Stuck BA, Groeben C, Gress TM, Wilhelm C, Hoffmann J, Rodepeter F, Wagner U, Neubauer A, Jesinghaus M, Wündisch T, Denkert C, Teply-Szymanski J.
Harb N, et al. Among authors: ruchholtz s.
Cancer Genet. 2026 Jun;304-305:103-113. doi: 10.1016/j.cancergen.2026.04.001. Epub 2026 Apr 3.
Cancer Genet. 2026.
PMID: 41950859
Free article.